Detalles de la búsqueda
1.
Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
Hematol Oncol
; 39(3): 313-325, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942348
2.
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms.
Hematol Oncol
; 38(3): 344-352, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383192
3.
Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms.
Eur J Haematol
; 103(5): 460-471, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31314918
4.
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
Eur J Haematol
; 98(3): 254-262, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27862308
5.
Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.
J Neurooncol
; 130(3): 591-599, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599828
6.
Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.
Hematol Oncol
; 33(1): 15-22, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24733536
7.
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry.
BMC Cancer
; 14: 806, 2014 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25371387
8.
Metronomic oral cyclophosphamide in patients with advanced solid tumors.
Onkologie
; 35(1-2): 35-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22310343
9.
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.
Clin Lymphoma Myeloma Leuk
; 22(8): e777-e787, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35624058
10.
Prospective multicenter randomized phase III study of weekly versus standard docetaxel (D2) for first-line treatment of metastatic breast cancer.
Oncology
; 79(3-4): 197-203, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21358207
11.
Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer.
Oncology
; 79(3-4): 204-10, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21358208
12.
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Cancer Med
; 9(13): 4527-4539, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32352244
13.
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Leukemia
; 34(4): 1038-1051, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32042081
14.
Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
Br J Haematol
; 144(1): 95-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19016732
15.
Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease.
Onkologie
; 32(4): 191-5, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19372714
16.
[Health services research: tumor registry for lymphatic neoplasia]. / Versorgungsforschung: Tumorregister Lymphatische Neoplasien.
Onkologie
; 36 Suppl 1: 27-8, 2013.
Artículo
en Alemán
| MEDLINE | ID: mdl-23445760
17.
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
Cancers (Basel)
; 11(1)2018 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30577662
18.
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
Breast
; 37: 42-51, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100043
19.
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.
Gynecol Oncol Res Pract
; 4: 6, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28286660
20.
Treatment of Non-transplant patients with multiple myeloma: routine treatment by office-based haematologists in Germany--data from the prospective Tumour Registry Lymphatic Neoplasms (TLN).
Oncol Res Treat
; 37(11): 635-6, 638-44, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25486127